Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Piper Sandler

Analysts Are Doubling Down on SoundHound AI Stock. Should You?

This analyst has provided a fresh rating on SoundHound with a positive outlook.

Barchart

Coming This Week: Get Ready for the ‘Last Wave of Negative News’ on Nvidia Stock

Piper Sandler is cautious on Nvidia before its Q1 report. But it expects it to be the last wave of negative news. Here’s why.

Barchart

Ahead of Q1 Earnings, Nvidia Is Working on a New Blackwell Chip for China. How Should You Play NVDA Stock Here?

Nvidia shares inch up on reports the AI giant plans on releasing a toned-down version of its Blackwell chip. Piper Sandler recommends sticking to NVDA stock ahead of Q1 earnings.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

BYD Just Outsold Tesla in Europe. Is It Time to Drop TSLA Stock Like It’s Hot?

BYD dethroned Tesla as Europe’s best-selling EV brand in April. Piper Sandler still recommends owning TSLA shares at current levels.

Barchart

Tesla: Get Ready To See It Trading Above $400 Again

Tesla rallies 40% post-earnings as Piper Sandler sets a bullish $400 target, betting big on autonomy and software-led margin expansion.

MarketBeat

Why Analysts Say the Worst-Case for Nvidia Stock in 2025 Is $77

This article examines why some analysts believe Nvidia stock could fall as low as $77 in 2025.

Barchart

Palantir Is Teaming Up With Google in Bid to Win More Gov Contracts. How Should You Play PLTR Stock Here?

Palantir announced an extended partnership with Google to integrate its cloud infrastructure into its FedStart initiative. But are PLTR shares worth owning at current levels?

Barchart

Read news from The Economist, FT, and more,
with one subscription

Trump’s Tariffs Are Hammering Meta Stock. Should You Buy the Dip or Wait It Out?

While Meta is still the best-performing Magnificent 7 stock, it has lost 26% from its highs.

Barchart

Forget Nvidia. This Analyst Is Recommending 3 Lesser-Known Stocks for the ‘Next Major AI Wave’

Consumer-facing applications could be the next big thing in AI investing.

Barchart

1 Analyst Just Raised His Price Target 220% on This Quantum Computing Stock

Piper Sandler’s triple-digit target hike on this quantum computing stock, due to its surging bookings and commercial traction, signals accelerating momentum for this quantum innovator.

Barchart

Stocks Settle Lower on Economic Uncertainty

The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.30%. March E-mini S&P futures (ESH25 ) are down -0.20%, and March E-mini Nasdaq futures...

Barchart

Stocks Climb as Strong US Economic News Eases Growth Concerns

The S&P 500 Index ($SPX ) (SPY ) today is up +0.44%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.49%. March E-mini S&P futures (ESH25 ) are up +0.35%, and March E-mini Nasdaq futures...

Barchart

Stocks Recover Early Losses as Bond Yields Fall

The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.27%. March E-mini S&P futures (ESH25 ) are down -0.14%, and March E-mini Nasdaq futures...

Barchart

Mediterranean Growth Monster: CAVA Keeps Surging—Buy the Dip?

CAVA Group posted amazing 21% YoY same restaurant sales in Q4, crushing Chipotle's 5.4% and Sweetgreen's 4% comps growth, yet shares fell 10% in reaction.

MarketBeat

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat

Why Salesforce Stock Could Be at Fresh Highs by February

One of the reasons we're so excited about Salesforce is the analysts' coverage of the stock. Just last week, TD Cowen upgraded it to a Buy.

Fortune

How Elon Musk built an AI moat around Tesla impervious to DeepSeek’s ‘Sputnik moment’

If anything, potentially less demand for Nvidia’s AI training chips could actually benefit the EV manufacturer.

MarketBeat

3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year

Check out these three defensive stocks that Wall Street analysts are upgrading their ratings on in the first few weeks of 2025.

MarketBeat

Why Nike Is on The Verge of a Massive Comeback Rally

The team at Piper Sandler just upgraded their rating on Nike from Neutral to Overweight, setting a fresh price target of $90.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Stocks Recover on Strength in Health Insurers and Energy Stocks

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.86%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.30%. March E-mini S&P futures (ESH25 ) are up +0.26%, and March E-mini Nasdaq futures...

Benzinga

The Latest Analyst Ratings For CME Gr

In the preceding three months, 18 analysts have released ratings for CME Gr (NASDAQ:CME), presenting a wide array of perspectives from bullish to bearish.

Benzinga

What 16 Analyst Ratings Have To Say About Murphy Oil

During the last three months, 16 analysts shared their evaluations of Murphy Oil (NYSE:MUR), revealing diverse outlooks from bullish to bearish.

Benzinga

Decoding 23 Analyst Evaluations For HubSpot

Providing a diverse range of perspectives from bullish to bearish, 23 analysts have published ratings on HubSpot (NYSE:HUBS) in the last three months.

Benzinga

Critical Insights From Ulta Beauty Analyst Ratings: What You Need To Know

Ratings for Ulta Beauty (NASDAQ:ULTA) were provided by 28 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Barchart

2 'Strong Buy' Biotech Stocks With 120% or More Upside Potential

With the growing demand for cutting-edge therapies reshaping the healthcare landscape, here are two “Strong Buy”-rated biotech stocks with significant potential upside.

Benzinga

DocuSign Stock Jumps On Strong Q3, Analysts Await Proof Of Sustained Growth

DocuSign stock climbed on better-than-expected Q3 results and strong guidance for Q4 and fiscal 2025, leading to price target increases from analysts.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations